Pancreatic cancer has long confounded medicine not merely because of the cancer itself, but because of the fortress it builds around itself — a living architecture of immune cells, fibers, and inflammatory signals that turns the body's own tissues against treatment. Researchers at the University of Miami have identified a protein called IL1RAP as the coordinating intelligence of this fortress, a single receptor through which many of the tumor's protective signals flow. By blocking it, they believe they can dismantle the shield before the weapons are even drawn — and a clinical trial is now bei